Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Jun 8, 2017 (9 years ago)

Diabecline brand Topical Ointment First Aid Antibiotic

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of unexpired drug products manufactured by the firm.

Cause type: Stability / shelf life

The product degraded or failed stability testing before its labeled expiry. Heat, moisture or time can break the drug down into degradants or reduce potency. All stability / shelf life recalls.

What was recalled

Diabecline brand Topical Ointment First Aid Antibiotic, tetracycline (3%), 3 mL in a 5 mL bottle, sold over the counter Phillips Company, Millerton, OK -- NDC 04307-100-11

Affected NDC 4307-0100-11

Compare with the code on your package — it is the most precise check available.

Drug: Tetracycline

Recalling firm
Phillips Co.
NDC code
04307-100-11
Origin
OK, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0949-2017 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Tetracycline recalls

See all
Class I · High risk

Tetracycline HCL Capsules

Failed Dissolution Specifications: Out of specification result during long term testing in Tetracycline HCl capsules.

Terminated Dissolution failure Avet Pharmaceuticals, Inc. NDC 23155-017-01 D-1255-2020
Class I · High risk

Tetracycline HCL Capsules

Failed Dissolution Specifications: Out of specification result during long term testing in Tetracycline HCl capsules.

Terminated Dissolution failure Avet Pharmaceuticals, Inc. NDC 23155-018-01 D-1254-2020
Class II · Moderate risk

Tetracycline HCl active pharmaceutical ingredient packaged in…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-924-2015

Other recalls by Phillips Co.

All 2017 recalls
Class II · Moderate risk

VenomX

GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of unexpired drug products manufactured by the firm.

Terminated Stability / shelf life Phillips Co. NDC 43074-207-01 D-0952-2017
Class II · Moderate risk

StaphWash+Plus+ Skin Protectant

GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of unexpired drug products manufactured by the firm.

Terminated Stability / shelf life Phillips Co. NDC 43074-101-01 D-0951-2017
Class II · Moderate risk

StingMed Insect bites Skin Protectant. Zinc acetate

GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of unexpired drug products manufactured by the firm.

Terminated Stability / shelf life Phillips Co. NDC 04307-100-11 D-0950-2017